Expression of Myostatin in Intrauterine Growth Restriction and Preeclampsia Complicated Pregnancies and Alterations to Cytokine Production by First-Trimester Placental Explants Following Myostatin Treatment
Restricted accessResearch articleFirst published online October, 2015
Expression of Myostatin in Intrauterine Growth Restriction and Preeclampsia Complicated Pregnancies and Alterations to Cytokine Production by First-Trimester Placental Explants Following Myostatin Treatment
Preeclampsia (PE) and intrauterine growth restriction (IUGR) are major obstetric health problems. Higher levels of T-helper (Th) 1 (proinflammatory) cytokines have been observed in pregnancies complicated with PE and IUGR; this is in contrast to the predominant Th2 (anti-inflammatory) cytokine environment found in uncomplicated pregnancies. Myostatin is best known as a negative regulator of muscle development and reportedly has a role in fat deposition, glucose metabolism, and cytokine modulation (outside the placenta). Myostatin concentrations in plasma and protein expression in placental tissue are significantly higher in women with PE. Expression of myostatin in IUGR and PE-IUGR and the effect of this protein on the cytokine production from the placenta is unknown. In the current study, significant differences were identified in the expression of myostatin in pregnancies complicated with IUGR, PE, and PE with IUGR. Furthermore, cytokine production by first-trimester placental tissues was altered following myostatin treatment.
KarumanchiSAMaynardSEStillmanIEEpsteinFHSukhatmeVP. Preeclampsia: a renal perspective. Kidney Int. 2005;67(6):2101–2113.
2.
Clinical indicator user manual 2012: Obstetrics version 7. RANZCOG/ACHS Obstetric Clinical Indicators 2011. 2012.
3.
RobertsDJPostMD. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol. 2008;61(12):1254–1260.
4.
ScifresCMNelsonDM. Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol. 2009;587(14):3453–3458.
5.
GuoJTianTLuDXiaGWangHDongM. Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia. J Obstet Gynaecol Res. 2012;38(7):988–996.
6.
HuDTianTGuoJWangHChenDDongM. Decreased maternal and placental concentrations of follistatin-like 3 in gestational diabetes. Clin Chim Acta. 2012;413(5-6):533–536.
7.
PeirisHNLappasMGeorgiouHM. Myostatin in the placentae of pregnancies complicated with gestational diabetes mellitus. Placenta. 2015;36(1):1–6.
8.
McPherronACLawlerAMLeeSJ. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature. 1997;387(6628):83–90.
9.
LeeSJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol. 2004;20:61–86.
10.
RodgersBDGarikipatiDK. Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr Rev. 2008;29(5):513–534.
11.
HillJJDaviesMVPearsonAA. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem. 2002;277(43):40735–40741.
12.
LeeSJ. Genetic analysis of the role of proteolysis in the activation of latent myostatin. PLoS One. 2008;3(2):e1628.
13.
PeirisHNMitchellMD. The expression and potential functions of placental myostatin. Placenta. 2012;33(11):902–907.
14.
JonesRLStoikosCFindlayJKSalamonsenLA. TGF-beta superfamily expression and actions in the endometrium and placenta. Reproduction. 2006;132(2):217–232.
15.
MitchellMDOsepchookCCLeungKCMcMahonCDBassJJ. Myostatin is a human placental product that regulates glucose uptake. J Clin Endocrinol Metab. 2006;91(4):1434–1437.
16.
AntonyNBassJJMcMahonCDMitchellMD. Myostatin regulates glucose uptake in BeWo cells. Am J Physiol Endocrinol Metab. 2007;293(5):E1296–E1302.
17.
PeirisHNPonnampalamAPOsepchookCCMitchellMDGreenMP. Placental expression of myostatin and follistatin-like-3 protein in a model of developmental programming. Am J Physiol Endocrinol Metab. 2010;298(4):E854–E861.
18.
PeirisHNSalomonCPaytonD. Myostatin is localized in extravillous trophoblast and up-regulates migration. J Clin Endocrinol Metab. 2014;99(11):E2288–E2297.
RegnaultTRHGalanHLParkerTAAnthonyRV. Placental development in normal and compromised pregnancies - A review. Placenta. 2002;23(suppl 1):S119–S129.
21.
KaufmannPBlackSHuppertzB. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69(1):1–7.
22.
HuppertzB. Placental pathology in pregnancy complications. Thromb Res2011;127(suppl 3):S96–S99.
23.
MayhewTMWijesekaraJBakerPNOngSS. Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia. Placenta. 2004;25(10):829–833.
24.
BowenJMChamleyLMitchellMDKeelanJA. Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta. 2002;23(4):239–256.
25.
SykesLMacIntyreDAYapXJTeohTGBennettPR. The Th1: Th2 dichotomy of pregnancy and preterm labour. Mediators Inflammation. 2012;2012:967629.
26.
ChallisJRLockwoodCJMyattLNormanJEStraussJFIIIPetragliaF. Inflammation and pregnancy. Reprod Sci. 2009;16(2):206–215.
27.
MullinsEPriorTRobertsIKumarS. Changes in the maternal cytokine profile in pregnancies complicated by fetal growth restriction. Am J Reprod Immunol. 2012;68(1):1–7.
28.
GomesCPTorloniMRGueuvoghlanian-SilvaBYAlexandreSMMattarRDaherS. Cytokine levels in gestational diabetes mellitus: a systematic review of the literature. Am J Reprod Immunol. 2013;69(6):545–557.
29.
RaghupathyRAl-AzemiMAziziehF. Intrauterine growth restriction: Cytokine profiles of trophoblast antigen-stimulated maternal lymphocytes. Clin Dev Immunol. 2012;2012:734865.
30.
SzarkaARigóJJrLázárLBekoGMolvarecA. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010;11:59.
31.
TosunMCelikHAvciBYavuzEAlperTMalatyalioǧluE. Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-α in normal pregnancies and in pregnancies complicated by preeclampsia. J Matern Fetal Med. 2010;23(8):880–886.
32.
FoundsSAPowersRWPatrickTE. A comparison of circulating TNF-alpha in obese and lean women with and without preeclampsia. Hypertens Pregnancy. 2008;27(1):39–48.
33.
HolcbergGHuleihelMSapirO. Increased production of tumor necrosis factor-α TNF-α by IUGR human placentae. Eur J Obstet Gynecol Reprod Biol. 2001;94(1):69–72.
34.
WilkesJJLloydDJGekakisN. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes. 2009;58(5):1133–1143.
35.
ZhangLRajanVLinE. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J. 2011;25(5):1653–1663.
36.
BonettoAPennaFMineroVG. Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by tumor necrosis factor-alpha. Amino Acids. 2011;40(2):585–594.
37.
CostelliPMuscaritoliMBonettoA. Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur J Clin Invest. 2008;38(7):531–538.
38.
ErmolovaNVMartinezLVetroneSA. Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function. Neuromuscul Disord. 2014;24(7):583–595.
39.
LoweSABrownMADekkerGA. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol. 2009;49(3):242–246.
40.
MunroSKMitchellMDPonnampalamAP. Histone deacetylase inhibition by trichostatin A mitigates LPS induced TNFα and IL-10 production in human placental explants. Placenta. 2013;34(7):567–573.
41.
SalomonCRyanJSobreviaL. Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One. 2013;8(7):e68451.
42.
BlumensteinMMitchellMDGroomeNPKeelanJA. Hypoxia inhibits activin A production by term villous trophoblast in vitro. Placenta. 2002;23(10):735–741.
43.
LappasMPermezelMRiceGE. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab. 2004;89(11):5627–5633.
44.
FoundsSARenDRobertsJMJeyabalanAPowersRW. Follistatin-Like 3 across gestation in preeclampsia and uncomplicated pregnancies among lean and obese women[published online April 3, 2014]. Reprod Sci. 2014.
45.
BanerjeeSSmallwoodAMoorheadJ. Placental expression of interferon-γ (IFN-γ) and its receptor IFN-γR2 fail to switch from early hypoxic to late normotensive development in preeclampsia. J Clin Endocrinol Metab. 2005;90(2):944–952.
46.
LashGEOtunHAInnesBA. Interferon-γ inhibits extravillous trophoblast cell invasion by a mechanism that involves both changes in apoptosis and protease levels. Faseb J. 2006;20(14):2512–2518.
47.
HaiderSKnoflerM. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta. 2009;30(2):111–123.
48.
Monzon-BordonabaFVadillo-OrtegaFFeinbergRF. Modulation of trophoblast function by tumor necrosis factor-alpha: a role in pregnancy establishment and maintenance?Am J Obstet Gynecol. 2002;187(6):1574–1580.
49.
De OliveiraLGLashGEMurray-DunningC. Role of interleukin 8 in uterine natural killer cell regulation of extravillous trophoblast cell invasion. Placenta. 2010;31(7):595–601.
50.
NaruseKInnesBABulmerJNRobsonSCSearleRFLashGE. Secretion of cytokines by villous cytotrophoblast and extravillous trophoblast in the first trimester of human pregnancy. J Reprod Immunol. 2010;86(2):148–150.
51.
deM-PMIVinceGSFlanaganBFHartCAJohnsonPM. Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes. Immunology. 1997;90(1):87–94.
CelikHAvciBAlperT. Comparison of maternal serum levels of interleukin-10, interleukin-12, and interleukin-2 in normal and preeclamptic pregnancies. Pregnancy Hypertens. 2012;2(1):39–42.
54.
BorekciBAksoyHAlRADemircanBKadanaliS. Maternal serum interleukin-10, interleukin-2 and interleukin-6 in pre-eclampsia and eclampsia. Am J Reprod Immunol. 2007;58(1):56–64.
55.
JauniauxEGulbisBBurtonGJ. Physiological implications of the materno-fetal oxygen gradient in human early pregnancy. Reprod Biomed Online. 2003;7(2):250–253.
56.
RodeschFSimonPDonnerCJauniauxE. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol. 1992;80(2):283–285.
